Anti-tumour necrosis factor treatment in a patient with anorexia nervosa and juvenile idiopathic arthritis [3]

Annals of the Rheumatic Diseases

Volumn 62, Issue 5, 2003, Pages 490-491

  Barber, J ^a   Sheeran, T ^a   Mulherin, D ^a  

^a ROYAL WOLVERHAMPTON HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANOREXIA NERVOSA; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DISEASE EXACERBATION; FAMILY THERAPY; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; PHYSIOTHERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; BODY WEIGHT; DRUG ANTAGONISM; DRUG EFFECT;

ADULT; ANOREXIA NERVOSA; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, JUVENILE RHEUMATOID; BODY WEIGHT; FEMALE; HUMANS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037404932     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.5.490     Document Type: Letter

References (10)

1. O'Dell JR. Anticytokine therapy a new era in the treatment of rheumatoid arthritis? N Engl J Med 1999;340:310-12.
2. Lovell DJ, Giannini EH, Reiff A, Cawkwell GD, Silvermann ED, Nocton JJ, et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis. N Engl J Med 2000;342:763-9.
3. Holden RJ, Pakula IS. The role of tumour necrosis factor-alpha in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses 1996;47:423-38.
4. Allende LM, Corell A, Manzanares J, Madruga D, Marcos A, Lopez-Goyanes A, et al. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology 1998;94:543-51.
5. Holden RJ, Pakula IS. Tumour necrosis factor-alpha: is there a continuum of liability between stress, anxiety states and anorexia nervosa? Med Hypotheses 1999;52:155-62.
6. van der Heijde DMFM, van't Hof MA, van Reil PLCM, Theunisse LAM, Lubberts EW, van Leeuwen MA, et al. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990;49:916-20.
7. Tanner JM, Buckler JM. Revision and update of Tanner-Whitehouse clinical longitudinal charts for height and weight. Eur J Paediatr 1997;156:248-9.
8. Lowe B, Zipfel S, Buchholz C, Dupont Y, Reas DL, Herzog W. Long-term outcome of anorexia nervosa in a prospective 21-year follow-up study. Psychol Med 2001;31:881-90.
9. Beutler B, Greenwald D, Hulmes JD, Chang M, Pan YC, Mathison J, et al. Identity of tumour necrosis factor and the macrophage secreted factor cachectin. Nature 1985;316:552-4.
10. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumour necrosis factor. J Rheumatol 1992;19:1505-10.